Literature DB >> 15074927

Synthesis of (+/-)-hamigeran B, (-)-hamigeran B, and (+/-)-1-epi-hamigeran B: use of bulky silyl groups to protect a benzylic carbon-oxygen bond from hydrogenolysis.

Derrick L J Clive1, Jian Wang.   

Abstract

Enone 42 was converted into diene 56, which was then subjected to hydrogenation. Use of the tert-butyldimethylsiloxy groups enforces facial selectivity and protects the C(5) oxygen from hydrogenolysis. The resulting product (55) is easily converted into hamigeran B (1), a marine natural product with powerful activity against herpes and polio viruses. Optically pure enone 73 was made by use of a Meyers' auxiliary and converted into (-)-hamigeran B with the natural absolute configuration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15074927     DOI: 10.1021/jo030347v

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  5 in total

1.  A catalytic, asymmetric formal synthesis of (+)-hamigeran B.

Authors:  Herschel Mukherjee; Nolan T McDougal; Scott C Virgil; Brian M Stoltz
Journal:  Org Lett       Date:  2011-01-27       Impact factor: 6.005

2.  Synthetic Studies toward the Hamigerans with a 6-7-5 Tricyclic Core.

Authors:  Baiyang Jiang; Mingji Dai
Journal:  Org Lett       Date:  2020-05-13       Impact factor: 6.005

3.  Synthesis of (-)-hamigeran B.

Authors:  Douglass F Taber; Weiwei Tian
Journal:  J Org Chem       Date:  2008-09-05       Impact factor: 4.354

4.  Progress towards the total synthesis of hamigerans C and D: a direct approach to an elaborated 6-7-5 carbocyclic core.

Authors:  Douglas Charles Duquette; Thomas Jensen; Brian Mark Stoltz
Journal:  J Antibiot (Tokyo)       Date:  2017-09-06       Impact factor: 2.649

5.  Stereospecific total synthesis of the indole alkaloid ervincidine. Establishment of the C-6 hydroxyl stereochemistry.

Authors:  Sundari K Rallapalli; Ojas A Namjoshi; V V N Phani Babu Tiruveedhula; Jeffrey R Deschamps; James M Cook
Journal:  J Org Chem       Date:  2014-04-18       Impact factor: 4.354

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.